<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<atom:link href="http://rss.en.redtram.com/catalogue/world/infectious-diseases/feed.xml" rel="self" type="application/rss+xml" />
<title>RedTram News Search Engine | News on &quot;Infectious Diseases&quot;  everywhere</title>
<link>http://en.redtram.com/</link>
<description>News on &quot;Infectious Diseases&quot;  everywhere</description>
<copyright>Copyright (c) 2009 RedTram. All rights reserved.</copyright>
<webMaster>webmaster@redtram.com (RedTram)</webMaster>
<language>en</language>
<lastBuildDate>Thu, 17 Dec 2009 02:33:27 GMT</lastBuildDate>
<ttl>300</ttl>
<image>
<title>RedTram News Search Engine | News on &quot;Infectious Diseases&quot;  everywhere</title>
<width>100</width>
<height>50</height>
<link>http://en.redtram.com/</link>
<url>http://img.en.redtram.com/rsslogo.gif</url>
</image>
<item>
<category>6058 | Encouraging Start for New HCV Treatment Concept</category>
<title>Encouraging Start for New HCV Treatment Concept</title>
<link>http://en.redtram.com/go/236188525/top100/</link>
<source url="http://en.redtram.com/sources/236188525/">236188525</source>
<description>By thinking outside the box, the Denmark-based company Santaris Pharma A/S has developed a drug targeting a specific molecule necessary for Hepatitis C replication. Although a very small trial, SPC3649 demonstrates a significant Hepatitis C viral load decline in primates.</description>
<pubDate>Sat, 12 Dec 2009 04:58:36 GMT</pubDate>
<guid isPermaLink="true">http://en.redtram.com/go/236188525/top100/</guid>
<enclosure url="http://img2.en.redtram.com/news/236188525.jpg" length="255" type="image/jpeg" />
</item>
</channel>
</rss>
